HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xunwei Shi Selected Research

niraparib

4/2024Olaparib and niraparib as maintenance therapy in patients with newly diagnosed and platinum-sensitive recurrent ovarian cancer: A single-center study in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xunwei Shi Research Topics

Disease

2Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 03/2021
1Breast Neoplasms (Breast Cancer)
04/2024
1Ovarian Epithelial Carcinoma
03/2021

Drug/Important Bio-Agent (IBA)

1niraparibIBA
04/2024
1olaparibIBA
04/2024
1Poly Adenosine Diphosphate RiboseIBA
04/2024
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2024
1PlatinumIBA
04/2024

Therapy/Procedure

1Therapeutics
04/2024
1Drug Therapy (Chemotherapy)
03/2021
1Neoadjuvant Therapy
03/2021